Michigan Senate Bill SB0107

Michigan 2025-2026 Regular Session

• Introduced: 2/26/25
• Refer: 2/26/25
• Report Pass: 3/20/25
• Refer: 3/20/25
• Report Pass: 4/17/25
• Engrossed: 4/22/25
• Refer: 4/22/25

Caption

Insurance: health insurers; coverage for immunization agents and certain laboratory tests administered and ordered by a pharmacist; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406ss.

Summary

SB 107 would require Michigan health insurers, beginning January 1, 2026, to cover certain services provided by pharmacists in network pharmacies when the policy already covers immunization agents. Specifically, the bill mandates coverage for CDC-listed immunizing agents administered by a pharmacist, as well as certain laboratory tests ordered by a pharmacist and drugs dispensed by a pharmacist under the relevant Public Health Code provisions. The bill applies only to policies delivered, issued for delivery, or renewed in Michigan that include immunization-agent coverage. The required coverage would still be subject to the insurer’s existing utilization management tools, including prior authorization and precertification, and insurers could apply normal cost-sharing such as deductibles, copayments, and coinsurance. In effect, the bill expands access to pharmacist-delivered preventive and related care while preserving many of the plan design controls insurers already use.

Impact

The bill would amend the Michigan Insurance Code by adding a new section, MCL 500.3406ss, creating a new coverage mandate for health insurance policies that cover immunization agents. It would also indirectly reinforce the pharmacist authority provisions in the Public Health Code by tying insurance coverage to services authorized under MCL 333.17724 and MCL 333.17724a. Affected parties include health insurers, pharmacy benefit structures, pharmacies in-network, pharmacists, and insured individuals seeking vaccines, related lab tests, or pharmacist-dispensed drugs.

Sentiment

The available voting history suggests the bill was generally well received. It was reported favorably out of committee without amendment on a 9-0 vote and then passed the Senate on third reading by a wide margin, 34-2. That pattern indicates broad support for expanding pharmacist-based access to immunization-related services, with only limited opposition at the floor stage.

Contention

The main policy tension appears to be between expanding coverage for pharmacist-provided care and preserving insurer controls over utilization and cost. Supporters likely favor easier access to vaccines, tests, and related medications through pharmacies, especially in-network pharmacies. Any opposition appears limited, but the bill’s retention of prior authorization, precertification, and cost-sharing suggests an effort to balance access with insurer concerns about utilization and expense.